Heartflow, Inc. (HTFL) insider trading

By person

11 insiders · 2 transactions

24.0×

John C.M. Farquhar holds 24.0 times base salary in stock. $15.57M of shares against $647.97K in salary for 2025.

Salary from the company's own proxy. The shares are what John C.M. Farquhar last reported holding, valued at $55.01, the price Common Stock was last bought or sold at on the open market here, on 22 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John C.M. Farquhar

Chief Executive Officer

—

$1.93M (1) scheduled

−$1.93M

283,014

0.3255%

$15.57M

−24.2%

Campbell Rogers

Chief Medical Officer

—

$1.32M (1) scheduled

−$1.32M

218,993

0.2519%

$12.05M

+50.5%

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

8,448,158

9.72%

$464.73M

—

Jeffrey C Lightcap

Director

—

4,909,223

5.65%

$270.06M

—

William C Weldon

Director

—

243,931

0.2805%

$13.42M

+333.5%

Timothy C Barabe

Director

—

188,231

0.2165%

$10.35M

+411.8%

Vikram Verghese

Chief Financial Officer

—

155,183

0.1785%

$8.54M

+35.2%

Casey M Tansey

Director

—

114,750

0.1320%

$6.31M

—

Marie L. Jones

Chief Accounting Officer

—

32,176

0.0370%

$1.77M

—

Julie A Cullivan

Director

—

27,291

0.0314%

$1.50M

−38.6%

HealthCor Partners Management LP entity

Director

—

0.0000%

$0.00

—

Heartflow, Inc.

What the insiders did Scheduled selling only

By person